División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, México.
Eur Rev Med Pharmacol Sci. 2023 Apr;27(7):3088-3095. doi: 10.26355/eurrev_202304_31943.
The aim of this investigation was to determine the frequency and association of the variants rs4817415, rs2070424, and rs1041740 of the SOD1 gene in healthy women and breast cancer (BC) patients.
Genomic DNA samples from 146 healthy women and 130 patients with BC were analyzed.
GG genotype (OR 2.54, 95% CI 1.31-4.91, p = 0.0073) and the G allele (OR 1.37, 95% CI 1.09-1.73, p = 0.007) of the rs2070424 variant and CC genotype (OR 1.67, 95% CI 1.04-0.2.70, p = 0.0444) and allele C (OR 1.58, 95% CI 1.09-2.29, p = 0.0183) of the rs1041740 variant of SOD1 gene were associated as risk factors for BC susceptibility relative to the control group. Study groups comparison of the stratification by menopausal status showed an association of susceptibility to BC risk with carriers of the GG genotype (OR 2.9, 95% CI 1.11-7.81, p = 0.042) of the rs2070424 variant and with the premenopausal status of the study group and the TT (OR 2.89, 95% CI 1.73-4.85, p = 0.001) genotype of the rs1041740 variant. Furthermore, differences were observed in the patients with BC who were carriers of the CC genotype of the rs4817415 variant with elevated Ki-67 (≥ 20%) and who presented lymph node metastasis and stage III-IV BC (p<0.05). Two common haplotypes were identified in the study groups: CAC (protective factor), and CGC (risk factor) (p<0.05).
The rs2070424 and rs1041740 variants of the SOD1 gene and the CGC haplotype were associated as risk susceptibility factors of BC in this sample analyzed.
本研究旨在确定 SOD1 基因 rs4817415、rs2070424 和 rs1041740 变异在健康女性和乳腺癌(BC)患者中的频率和相关性。
对 146 名健康女性和 130 名 BC 患者的基因组 DNA 样本进行分析。
rs2070424 变异的 GG 基因型(OR 2.54,95%CI 1.31-4.91,p = 0.0073)和 G 等位基因(OR 1.37,95%CI 1.09-1.73,p = 0.007),rs1041740 变异的 CC 基因型(OR 1.67,95%CI 1.04-0.2.70,p = 0.0444)和 C 等位基因(OR 1.58,95%CI 1.09-2.29,p = 0.0183)与 BC 易感性相关,是对照组的危险因素。对按绝经状态分层的研究组进行比较,发现 rs2070424 变异的 GG 基因型(OR 2.9,95%CI 1.11-7.81,p = 0.042)携带者和研究组的绝经前状态与 BC 风险易感性相关,rs1041740 变异的 TT(OR 2.89,95%CI 1.73-4.85,p = 0.001)基因型也是如此。此外,还观察到携带 rs4817415 变异的 CC 基因型的 BC 患者的差异,这些患者的 Ki-67(≥ 20%)升高,并且存在淋巴结转移和 III-IV 期 BC(p<0.05)。在研究组中鉴定出两种常见的单倍型:CAC(保护因素)和 CGC(危险因素)(p<0.05)。
在本研究样本中,SOD1 基因的 rs2070424 和 rs1041740 变异以及 CGC 单倍型与 BC 的易感性相关,是其风险易感性因素。